Fibrinogen is an efficient antioxidant

Journal of Nutritional Biochemistry

Volumn 12, Issue 3, 2001, Pages 162-169

  Olinescu, Radu M ^a,b   Kummerow, Fred A ^a,b  

^a Burnsides Research Laboratory   (United States)

^b Harlan E Moore Heart Research Foundation   (United States)

Author keywords

Antioxidants; Atherosclerosis; Fibrinogen; Oxygen free radicals

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; ANTIOXIDANT; AZO COMPOUND; CATALASE; CERULOPLASMIN; COPPER; CYTOCHROME C; DEOXYRIBOSE; FERROUS ION; FIBRINOGEN; HYDROGEN PEROXIDE; HYDROXYL RADICAL; LOW DENSITY LIPOPROTEIN; OXYGEN RADICAL; PYROGALLOL; SUPEROXIDE; SUPEROXIDE DISMUTASE; TRANSFERRIN; TROLOX C; XANTHINE; XANTHINE OXIDASE;

ARTICLE; ATHEROSCLEROSIS; AUTOOXIDATION; CATALYSIS; CHEMICAL REACTION; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; OXIDATION; OXIDATIVE STRESS; REDUCTION; RISK FACTOR; VASCULAR DISEASE;

EID: 0035090120     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(00)00147-9     Document Type: Article

References (48)

1. Fibrinogen as risk factor for stroke and myocardial infarction
2. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors
3. Regulation by fibrinogen and its products of intercellular adhesion molecule-1 expression in human saphenous vein endothelial cells
4. Fibrinogen, angina and coronary heart disease in a Chinese population
5. Determinants of population changes in fibrinogen and factor VII over 6 years; the Atherosclerosis Risk in Communities (ARIC) Study
6. Association between job characteristics and plasma fibrinogen in normal working population; a cross sectional analysis in referents of the SHEEP study. Stockholm Heart Epidemiology Program
7. Measuring plasma fibrinogen to predict stroke and myocardial infarction; an update
8. Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly
9. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies
10. Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin
11. The yin and yang of oxidation in the development of the fatty streak
12. Oxidants and antioxidants in the pathogenesis of atherosclerosis; implications for the oxidized low density lipoprotein hypothesis
13. Elevated plasma lipid hydroperoxides in patients with coronary artery disease
14. Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease
15. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease
16. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk
17. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenylenediamine
18. Garlic compounds protect vascular endothelial cells from oxidized low density lipoprotein-induced injury
19. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro
20. A delayed and sustained rise of cytosolic calcium is elicited by oxidized LDL in cultured bovine aortic endothelial cells
21. Lipoproteins and inflammation in atherosclerosis
22. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-)
23. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma
24. Antioxidant properties of the proteins ceruloplasmin, albumin and transferrin. A study of their activity in serum and synovial fluid from patients with rheumatoid arthritis
25. In vitro formation of oxidatively-modified and reassembled human low-density lipoproteins antioxidant effect of albumin
26. Inhibition of metal-catalyzed oxidation of low-density lipoprotein by free and albumin-bound bilirubin
27. The relationship of oxidized lipids to coronary artery stenosis
28. How to characterize a biological antioxidant
29. Antioxidant characterization; methodology and mechanism
30. Aminophylline; could it act as an antioxidant in vivo?
31. Ceruloplasmin a scavenger of superoxide anion radicals
32. Effects of taurine and hypotaurine on lipid peroxidation
33. Copper salt-dependent hydroxyl radical formation. Damage to proteins acting as antioxidants
34. Supplementation with beta-carotene in vivo and in vitro does not inhibit low density lipoprotein oxidation
35. An improvement of the Coomassie blue-dye binding method allowing an equal intensity to various proteins; application to cerebrospinal fluid
36. A simple chemiluminescent system for the determination of total antioxidant capacity
37. Albumin-an important extracellular antioxidant?
38. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. use of monoclonal antibodies
39. Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin
40. On the significance of chemiluminescence induced by the blood polymorphonuclear leukocytes
41. Inhibition of neutrophil activation by fibrinogen
42. Fibrinogen as a cardiovascular risk factor; a meta-analysis and review of the literature
43. Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation
44. Differential susceptibility of plasma proteins to oxidative modification; examination by western blot immunoassay
45. Free radical-induced fibrinogen coagulation; modulation of neofibe formation by concentration, pH and temperature
46. Role of carbohydrates in oxidative modification of fibrinogen and other plasma proteins